KIT and testicular cancer: These results indicate that HOXA10 not only stimulates the TP53-p21 axis, but also suppresses the cKit and STAT3 pathways to inhibit testicular cell proliferation (Figure 5D), supporting that loss of HOXA10 functions is associated with testicular cancers.